UBS O'Connor’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,400
Closed -$668K 300
2025
Q2
$668K Buy
+6,400
New +$678K 0.02% 255
2024
Q4
Sell
-15,666
Closed -$1.41M 447
2024
Q3
$1.41M Buy
15,666
+548
+4% +$47.8K 0.03% 235
2024
Q2
$1.22M Buy
15,118
+6,200
+70% +$459K 0.03% 270
2024
Q1
$712K Sell
8,918
-3,004
-25% -$252K 0.02% 308
2023
Q4
$949K Sell
11,922
-13,813
-54% -$923K 0.03% 276
2023
Q3
$1.8M Hold
25,735
0.03% 260
2023
Q2
$1.85M Buy
25,735
+3,169
+14% +$234K 0.04% 313
2023
Q1
$1.39M Buy
+22,566
New +$1.48M 0.03% 377
2022
Q4
Sell
-5,000
Closed -$223K 49
2022
Q3
$223K Sell
5,000
-23,026
-82% -$1.15M ﹤0.01% 843
2022
Q2
$1.07M Buy
+28,026
New +$886K 0.01% 750

Other funds holding AXSM